Home arrow Business arrow Pharmaceutical Industry arrow Akzo Nobel sells drugs unit to Schering-Plough for 11 bln euros
Stock MarketsU.S. EconomyEuropean Business & EconomyCompany Earnings
Personal FinancePharmaceutical IndustryReal Estate Industry
Akzo Nobel sells drugs unit to Schering-Plough for 11 bln euros
AFP   Monday, 12 March 2007

An Intervet employee looks at cells in his laboratory in Boxmeer, the Netherlands, August 2005. Intervet is part of the Dutch-Swedish pharmaceutical group Akzo Nobel, which has said that it has agreed to sell its Organon BioSciences drugs unit to US rival Schering-Plough for 11 billion euros (14.4 billion dollars).(AFP/ANP/File/Lex Van Lieshout)AFP - Dutch-Swedish pharmaceutical group Akzo Nobel said on Monday that it had agreed to sell its Organon BioSciences drugs unit to US rival Schering-Plough for 11 billion euros (14.4 billion dollars).
Read more...